Study guide
1.10 Physical & Psychological Development
Certified Genetic Counselor CGC
Track your progress as you read
Finished sections get a check mark.
1 Introduction & Exam Overview
1.1 About the CGC Exam & Credential 1.2 Eligibility Categories, Application & Fees 1.3 Scoring, Pass Rate & Test-Day Logistics
2 Domain 1A: Clinical Information
1.4 Medical & Pregnancy History 1.5 Teratogens, Exposures & Non-Genetic Risk Factors 1.6 Differential Diagnosis, Indication & Referral Urgency 1.7 Referral Triage, Case Preparation & Records Review
3 Domain 1B: Human Development
1.8 Fetal Development 1.9 Developmental Milestones 1.10 Physical & Psychological Development
4 Domain 1C: Chromosomal & Contiguous Gene Syndromes
1.11 Aneuploidy Syndromes (Down, Turner, Klinefelter, Edwards, Patau) 1.12 Microdeletion Syndromes (22q11.2, Williams, and Related) 1.13 Imprinting Disorders (PWS, Angelman, Beckwith-Wiedemann, Russell-Silver)
5 Domain 1C: Hereditary Cancer Syndromes
1.14 Hereditary Breast & Ovarian Cancer (BRCA1/2, PALB2, and Related) 1.15 Lynch Syndrome & Polyposis Syndromes 1.16 Li-Fraumeni, VHL, MEN, NF1/NF2 & Other Cancer Predisposition
6 Domain 1C: Metabolic, Neuromuscular & Multisystem Conditions
1.17 Inborn Errors of Metabolism & Storage Disorders 1.18 Neuromuscular Disease & Fragile X Spectrum 1.19 Connective Tissue & Cardiovascular Genetics 1.20 Screening, Surveillance, Treatment & Diagnostic Strategy Framework
7 Domain 2A: Pedigree & Risk Assessment
2.1 Family History, Pedigree Construction & Analysis 2.2 Mendelian Risk Calculations 2.3 Bayesian Risk Calculations 2.4 Empiric Risk, Multifactorial Recurrence & Risk-Assessment Models 2.5 Residual Risk & Follow-Up Medical Plans
8 Domain 2B: Inheritance Principles
2.6 Mendelian Inheritance Patterns 2.7 Non-Mendelian Inheritance (Mitochondrial, Imprinting, Multifactorial) 2.8 Penetrance, Expressivity, Anticipation & Heterogeneity 2.9 Mosaicism, X-Inactivation & Epigenetic Modifiers of Phenotype
9 Domain 2B: Population Genetics & Variation
2.10 Population Genetics, HWE & Quantitative Genetics 2.11 Human Genetic Variation & Disease Susceptibility
10 Domain 3A: Test Methodologies
3.1 Karyotype, FISH & Chromosomal Microarray 3.2 Molecular Diagnostics (Sanger, NGS Panels, WES, WGS, MLPA) 3.3 Sample Types, Clinical Context & Predictive Metrics
11 Domain 3A: Variant Interpretation
3.4 ACMG/AMP Variant Classification 3.5 Reanalysis, Reclassification & Validity/Utility Framework
12 Domain 3B: Testing Options
3.6 Diagnostic Testing Strategies 3.7 Screening Testing (including Newborn Screening) 3.8 Predictive & Pre-symptomatic Testing 3.9 Carrier, Somatic & Research Testing
13 Domain 3C: Reproductive Risk Management
3.10 Assisted Reproductive Technologies & PGT 3.11 Family Planning & Reproductive Options 3.12 Prenatal Screening (NIPT, Serum Markers) 3.13 Prenatal Diagnostic Procedures (CVS, Amniocentesis)
14 Domain 4A: Counseling Foundations
4.1 Contracting & Interviewing Techniques 4.2 Psychosocial Assessment, Follow-Up & Family Dynamics 4.3 Client Personal Identity & Cultural Humility
15 Domain 4A: Theories, Coping & Dynamics
4.4 Counseling Theories & Models (REM, Trajectory) 4.5 Defense Mechanisms, Coping & Decision-Making Styles 4.6 Grief, Perinatal Loss & Crisis Response 4.7 Self-Awareness & Client-Counselor Dynamics
16 Domain 4B: Communication & Education
4.8 Delivery Modes & Working with Interpreters 4.9 Risk Communication Theories & Models 4.10 Results Delivery & Long-Term Follow-Up 4.11 Health Literacy, Informed Consent & Informed Decision Making
17 Domain 5A–B: Finance & Client Resources
5.1 Insurance Policies, Billing & Letters of Medical Necessity 5.2 Billing, Coding & Reimbursement Compliance 5.3 Client Resources, Appropriateness & Timely Delivery
18 Domain 5C: Legal & Regulatory Requirements
5.4 GINA & Genetic Non-Discrimination Legislation 5.5 Privacy, Confidentiality, Documentation & Genomic Data Security 5.6 Human-Subjects Research Standards & Patient Access to Information 5.7 CLIA, Laboratory-Developed Tests & FDA Oversight 5.8 Genomic Data Security, DTC Testing & Data Sharing
19 Domain 5D: Professional Frameworks
5.9 NSGC Code of Ethics & Ethical Decision Making 5.10 Scope of Practice, Clinical Supervision & Conflict of Interest 5.11 Licensure, Credentialing & Maintaining the CGC Credential 5.12 Evidence-Based Practice & Professional/Public Education
20 Integration & Exam Strategy
6.1 Integrating Domains in Case-Based Practice & Exam Strategy
1.10 Physical & Psychological Development
Key Takeaways Explain This Topic AI
Serial growth parameters—weight, length/height, and head circumference—interpreted on appropriate charts (including syndrome-specific charts when available) are essential genetics intake data
Microcephaly and macrocephaly, short/tall stature, and asymmetric growth patterns redirect differentials toward specific genetic, endocrine, and syndromic evaluations
Pubertal timing and Tanner staging matter for counseling in disorders of sex development, endocrine-genetic conditions, and adolescent reproductive genetics
Psychosocial development across the lifespan shapes assent, decision-making capacity, and how families adapt to pediatric versus adult-onset genetic diagnoses
Adolescent assent plus parental permission, and later autonomous adult consent for predictive testing, are counseling competencies tied to developmental stage—not only legal age cutoffs
Last updated: August 2026
1.10 Physical & Psychological Development
Quick Answer: Plot growth (weight, length/height, head circumference) over time; abnormal trajectories (especially head size) reshape the genetics differential. Pair physical findings with psychosocial stage: children need developmentally appropriate explanations, adolescents need assent with parental permission, and adults facing adult-onset disease need autonomy-focused predictive counseling.
Domain 1B closes the human-development triad by moving from fetal timelines and childhood milestones into growth, puberty, and lifespan psychology —the scaffolding for how genetic counselors take histories and adapt sessions from prenatal through geriatric consults.
Growth Parameters as Genetic Data
Every genetics intake should capture growth with dates, not a single casual “small child” remark.
Parameter What to record Genetics relevance
Weight Birth weight and serial weights IUGR vs postnatal failure to thrive; metabolic wasting; overgrowth syndromes
Length / height Birth length; childhood height SDS/percentiles Short stature syndromes, skeletal dysplasias, endocrine-genetic disease; tall stature / Marfanoid habitus
Head circumference (OFC) Birth OFC and serial OFC Microcephaly and macrocephaly are high-yield genetics clues
Growth velocity Change over time, not one point Deceleration after normal birth size suggests postnatal-onset processes (e.g., some Rett presentations, acquired microcephaly)
Use WHO/CDC charts as appropriate for age, and syndrome-specific growth charts when available (e.g., Down syndrome, Turner syndrome) so you do not mislabel expected syndromic growth as a new pathologic failure—or miss superimposed problems.
Interpreting Extremes
Finding Counseling / differential anchors
Primary microcephaly (present at birth) Consider genetic primary microcephaly genes, prenatal injury, congenital infection; pair with development and imaging history
Acquired / postnatal microcephaly Decelerating OFC after birth—Rett spectrum, metabolic disease, neglect/medical illness—timeline is diagnostic
- Macrocephaly Benign familial macrocephaly vs hydrocephalus vs overgrowth/PTEN-related and other syndromes
- Disproportionate short stature Skeletal dysplasia pathway; not all short stature is “familial”
Asymmetric growth / hemihyperplasia Beckwith-Wiedemann spectrum and related overgrowth—tumor surveillance counseling may follow
Body mass and adiposity patterns (e.g., truncal obesity with hypotonia in Prader-Willi) also belong in the physical-development narrative.
Puberty and Sexual Development
Tanner staging (secondary sexual characteristics) helps frame delayed puberty, premature puberty, and disorders of sex development (DSD) counseling.
Concept Why genetic counselors care
Delayed puberty Turner syndrome, Klinefelter syndrome, hypogonadotropic hypogonadism genetic forms, chronic disease
Precocious puberty Occasionally syndromic; more often endocrine—but still appears in complex differentials
Primary amenorrhea / incomplete puberty Chromosomal and genetic DSD evaluations; sensitive psychosocial counseling
Fertility implications Many genetic diagnoses affect reproductive options counseling in adolescence and adulthood
Puberty is also when many families first confront reproductive genetics for the adolescent themselves (carrier status known from family testing, transition from pediatric to adult clinics, discussions of inheritance).
Exam tip: match the developmental stage to the counseling task—explaining infertility risk to a 16-year-old requires different pacing and assent practices than explaining the same content to a 35-year-old.
Psychosocial Development Across the Lifespan
Genetic counseling is applied developmental psychology. You do not need to recite every theorist, but you must adapt process to stage.
Life stage Developmental themes Counseling adaptations
Infancy / toddler Attachment, parental guilt/blame after diagnosis Support caregiver coping; concrete care plans; sibling attention
Early childhood Magical thinking, limited abstract risk concepts Simple language; play-based rapport when child present; parent-focused decisions
School age Industry vs inferiority; peer comparison Honest, age-fit explanations of “why clinic”; school/IEP resource links
Adolescence Identity, autonomy, body image, peer acceptance Private time; assent ; explore what the teen wants to know; social media and stigma
Young adulthood Independence, relationships, career, reproduction Transition of care; reproductive risk; insurance/GINA-aware practical planning
Midlife Caregiving sandwich, predictive testing for adult-onset disease Motivations for knowing vs not knowing; family communication
Older adulthood Legacy, competency concerns, cascade testing of children Respect autonomy; assess decision-making supports; avoid ageist assumptions
Adolescent Assent vs Consent
In pediatric genetics, parents/guardians typically provide permission (consent) for clinical care and testing, while the adolescent provides assent —an affirmative agreement aligned with their understanding. Best practice includes:
- Explaining the purpose of the visit and test in developmentally appropriate language
- Offering private time away from parents when safe and appropriate
- Documenting dissent and exploring it rather than steamrolling
Recognizing that legal age of majority and local policy define consent capacity, while ethical assent begins earlier
Predictive testing for adult-onset conditions in minors is constrained by professional guidelines precisely because of developmental and psychosocial risks—know that the default is often to defer predictive testing for untreatable adult-onset disease until adulthood unless there is a clear childhood medical benefit.
Adult-Onset Disease and Developmental Framing
Adult-onset counseling (Huntington disease, many cardiomyopathies, hereditary cancer syndromes, later-onset neurologic disease) differs from congenital/pediatric developmental genetics:
Pediatric / congenital focus Adult-onset focus
Explain cause of existing features or developmental differences Decide whether to learn future risk before symptoms
- Parents as primary decision makers Competent adult as primary decision maker
- Surveillance often starts in childhood Surveillance/risk-reducing options may be age-triggered
- School and developmental services Employment, insurance perceptions, reproductive timing, cascade testing
Motivations matter: a 25-year-old seeking BRCA1 testing before family planning is in a different psychosocial position than a 25-year-old pressured by relatives to test “for the family’s sake.” Assess readiness, coping, and support—not only the Bayesian risk number.
Integrating Physical and Psychological Data in One Session
A high-yield CGC habit is to weave streams together:
Plot growth and puberty status → refine the medical differential.
Note developmental and educational history → severity and functional impact.
Gauge the patient’s cognitive and emotional developmental stage → choose language, assent/consent process, and decision tools.
For adult-onset indications → explicitly address living with uncertainty, timed screening, and family communication plans.
Physical development without psychosocial framing produces incomplete counseling; psychosocial skill without growth/puberty literacy misses medical red flags. Domain 1B expects both.